1-6 of 6
Vijaya Pooja Vaikari
Close
Sort by
Journal Articles

Development of Anti-CD99scFvs for the Treatment of Acute Myeloid Leukemia

Yang Zhao, Jiawei Li, Vijaya Pooja Vaikari, Albert Lam, Atham Ali, Ophelia Meng, George Yaghmour, Yong Zhang, Houda Alachkar
Journal: Blood
Blood (2021) 138 (Supplement 1): 4345.
https://doi.org/10.1182/blood-2021-154304
Published: 2021
Journal Articles

Functional Analysis of CD99 Upregulation in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Jiawen Yang, BS, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5129.
https://doi.org/10.1182/blood-2018-99-120348
Published: 2018
Journal Articles

CD97 Is Associated with Poor Overall Survival in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Houda Alachkar, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2794.
https://doi.org/10.1182/blood-2018-99-120324
Published: 2018
Journal Articles

APOC2 Is Upregulated in Acute Myeloid Leukemia and Presents a Novel Therapeutic Target

Tian Zhang, BS, Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Donna Alexandra Loza, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2483.
https://doi.org/10.1182/blood.V130.Suppl_1.2483.2483
Published: 2017
Journal Articles

Interaction between FLT3 and CD99 in Acute Myeloid Leukemia

Vijaya Pooja Vaikari, MS, Sharon Wu, BS, Tian Zhang, BS, Sasha Kartman, Manal Abdi, Klaus H. Metzeler, MD, Mojtaba Akhtari, MD, Houda Alachkar, PharmD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3786.
https://doi.org/10.1182/blood.V130.Suppl_1.3786.3786
Published: 2017
Journal Articles

CD99 Is Highly Expressed in Acute Myeloid Leukemia (AML) and Presents a Viable Therapeutic Target

Vijaya Pooja Vaikari, MS, Miran Jang, PhD, Mojtaba Akhtari, MD, Houda Alachkar, PhD PharmD
Journal: Blood
Blood (2016) 128 (22): 1540.
https://doi.org/10.1182/blood.V128.22.1540.1540
Published: 2016